Devices for forming collateral channels and related methods of use

Patent metadata

Field	Value
Publication number	US-9693854-B2
Application number	US-201514672862-A
Country	US
Kind code	B2
Filing date	Mar 30, 2015
Priority date	Mar 31, 2014
Publication date	Jul 4, 2017
Grant date	Jul 4, 2017

Abstract

A method for treating a lung may include forming a channel between a first airway and a second airway through a tissue of the lung to allow air trapped within the first airway to flow through the channel and the second airway, and inserting a support member into the channel.

First claim

What is claimed is:

1. A method for treating a lung, the method comprising:
forming a channel between a first airway and a second airway through a tissue of the lung to allow air trapped within the first airway to flow through the channel and the second airway; and
inserting a support member into the channel, wherein an entirety of the support member is biodegradable, and the support member includes an outer member that is permeable to gases and impermeable to liquids.

2. The method of claim 1 , wherein the tissue of the lung includes parenchymal tissue of the lung.

3. The method of claim 1 , wherein the channel extends through a third airway.

4. The method of claim 1 , wherein the tissue of the lung includes alveoli.

5. The method of claim 1 , wherein the support member is a spiral member.

6. The method of claim 1 , wherein the support member is inserted via a bronchoscopic member, the support member remains in the channel after the bronchoscopic member has been removed from the lung, the support member is coupled to the distal end of the bronchoscopic member by a frangible link, and the frangible link is severed to secure the support member within the channel.

7. The method of claim 1 , wherein the support member includes:
a proximal end and a distal end; and
a valve at the proximal end to prevent inhalation of air mucus, and allow for exhalation of air.

8. The method of claim 1 , wherein, after degradation of the support member, the channel is defined only by the tissue of the lung.

9. The method of claim 8 , wherein the support member includes a biodegradable polymer.

10. The method of claim 1 , wherein the outer membrane is configured to degrade before a remainder of the support member degrades.

11. The method of claim 10 , wherein the support member is a spiral member that coils around a central lumen.

12. The method of claim 11 , wherein the support member further includes a bronchodilator.

13. A method for treating lungs, the method comprising:
coupling a first airway in a left lung of a patient and a second airway in a right lung of the patient, or coupling a first lung lobe of the patient and a second lung lobe of the patient, through a support member that extends through a pleural cavity of the patient to increase a forced expiratory volume of the lungs, wherein a first end of the support member is inserted into the left lung, and a second end of the support member is inserted into the right lung, or the first end of the support member is inserted into the first lung lobe and the second end of the support member is inserted into the second lung lobe.

14. The method of claim 13 , wherein at least a portion of the support member is biodegradable and includes a biodegradable polymer.

15. A method for treating a lung, the method comprising:
forming a plurality of channels from an airway and through emphysematous alveoli disposed adjacent the airway; and
inserting a support member into the lung, the support member including a branch point and at least three arms each extending radially outward from the branch point, wherein each of the plurality of channels receives one of the at least three arms, the support member further includes a biodegradable polymer, and an outer member that is permeable to gases and impermeable to liquids, and after degradation of the support member, each of the plurality of channels is defined only by the tissue of the lung.

16. The method of claim 15 , wherein an entirety of the support member is biodegradable.

Assignees

• Boston Scient Scimed Inc

Inventors

• Clark Bryan Allen
• Flanagan Aiden
• Schmidt Brian L

Classifications

• A61F2250/0071

  breakable or frangible · CPC title

• A61F2002/043

  Bronchi · CPC title

• A61F2/04 Primary

  Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts (A61F2/18, A61F2/20 take precedence; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95) · CPC title

• A61F2210/0004

  bioabsorbable · CPC title